These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2196260)

  • 1. Cefepime concentrations in bronchial mucosa and serum following a single 2 gram intravenous dose.
    Chadha D; Wise R; Baldwin DR; Andrews JM; Ashby JP; Honeybourne D
    J Antimicrob Chemother; 1990 Jun; 25(6):959-63. PubMed ID: 2196260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the penetration of ciprofloxacin and amoxycillin into the bronchial mucosa.
    Honeybourne D; Andrews JM; Ashby JP; Lodwick R; Wise R
    Thorax; 1988 Sep; 43(9):715-9. PubMed ID: 3194878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration of meropenem in serum and in bronchial secretions in patients undergoing fibreoptic bronchoscopy.
    Bergogne-Bérézin E; Muller-Serieys C; Aubier M; Dombret MC
    Eur J Clin Pharmacol; 1994; 46(1):87-8. PubMed ID: 8005193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
    Roos JF; Bulitta J; Lipman J; Kirkpatrick CM
    J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple dose pharmacokinetics, safety, and effects on faecal microflora, of cefepime in healthy volunteers.
    Bächer K; Schaeffer M; Lode H; Nord CE; Borner K; Koeppe P
    J Antimicrob Chemother; 1992 Sep; 30(3):365-75. PubMed ID: 1452502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and tissue penetration of cefepime.
    Nye KJ; Shi YG; Andrews JM; Wise R
    J Antimicrob Chemother; 1989 Jul; 24(1):23-8. PubMed ID: 2777727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of temafloxacin in serum and bronchial mucosa.
    Baldwin DR; Wilkinson L; Andrews JM; Ashby JP; Wise R; Honeybourne D
    Eur J Clin Microbiol Infect Dis; 1990 Jun; 9(6):432-4. PubMed ID: 2387297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentrations of cefpodoxime in serum and bronchial mucosal biopsies.
    Baldwin DR; Wise R; Andrews JM; Honeybourne D
    J Antimicrob Chemother; 1992 Jul; 30(1):67-71. PubMed ID: 1429338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The penetration of fleroxacin into bronchial mucosa.
    Wise R; Honeybourne D; Andrews JM; Ashby JP
    J Antimicrob Chemother; 1988 Aug; 22(2):203-6. PubMed ID: 3141344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous infusion versus intermittent administration of cefepime in patients with Gram-negative bacilli bacteraemia.
    Jaruratanasirikul S; Sriwiriyajan S; Ingviya N
    J Pharm Pharmacol; 2002 Dec; 54(12):1693-6. PubMed ID: 12542901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of cefodizime in bronchial secretions after single intravenous administration.
    Pacheco Y; Pirollet B; Taviot B; Coppere B; Perrin-Fayolle M; Dagrosa EE; Damm D
    Arzneimittelforschung; 1993 Aug; 43(8):924-6. PubMed ID: 8216455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic concentrations of cefepime.
    Delcenserie R; Dellion-Lozinguez MP; Yzet T; Lepointe B; Hary L; Badoui R; Verhaeghe P; Andrejak M; Dupas JL
    J Antimicrob Chemother; 2001 May; 47(5):711-3. PubMed ID: 11328792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of amoxycillin/clavulanic acid into bronchial mucosa with different dosing regimens.
    Gould IM; Harvey G; Golder D; Reid TM; Watt SJ; Friend JA; Legge JS; Douglas JG
    Thorax; 1994 Oct; 49(10):999-1001. PubMed ID: 7974318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute-phase response alters the disposition kinetics of cefepime following intravenous administration to rabbits.
    Abd El-Aty AM; Goudah A; Mouneir SM; Sunwoo YE; Jang JH; Shin JG; Shim JH; Shimoda M
    Vet Res Commun; 2007 Jan; 31(1):67-75. PubMed ID: 17186405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchial penetration of ofloxacin after single and multiple oral dosage.
    Davey PG; Precious E; Winter J
    J Antimicrob Chemother; 1991 Mar; 27(3):335-41. PubMed ID: 2037539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy.
    Andrews JM; Honeybourne D; Brenwald NP; Bannerjee D; Iredale M; Cunningham B; Wise R
    J Antimicrob Chemother; 1997 Jun; 39(6):797-802. PubMed ID: 9222050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular penetration of cefepime following systemic administration in humans.
    Ozdamar A; Aras C; Ozturk R; Karacorlu M; Bahcecioglu H; Ozkan S
    Ophthalmic Surg Lasers; 2001; 32(1):25-9. PubMed ID: 11195739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of cefdinir, a third generation cephalosporin antibiotic, in serum and pulmonary compartments.
    Cook PJ; Andrews JM; Wise R; Honeybourne D
    J Antimicrob Chemother; 1996 Feb; 37(2):331-9. PubMed ID: 8707743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The penetration of novel intravenous cephalosporins into the lung.
    Baldwin DR
    J Chemother; 1996 Feb; 8 Suppl 2():71-82. PubMed ID: 8738849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentrations of cefepime (BMY-28142), a broad-spectrum cephalosporin, in dogs.
    Stampley AR; Brown MP; Gronwall RR; Castro L; Stone HW
    Cornell Vet; 1992 Jan; 82(1):69-77. PubMed ID: 1740062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.